Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Marsh

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Aesthetic Plastic Surgery|February 9, 2026
Nationwide Analysis of Post-traumatic Breast Implant Complications: Predictors of Immediate vs Delayed Diagnosis and ManagementJade E Smith, Noelle C Garbaccio, Dorien I Schonebaum, et al.
Anticancer Research|August 5, 2010
Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumourAlicia F C Okines, Eliza A Hawkes, Sheela Rao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2018
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation OutcomesMojibade Hassan, Alina Ulezko Antonova, Jian Ming Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic miceLi-Zhen He, Naseem Prostak, Lawrence J Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemiaLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-primingMark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Aesthetic Plastic Surgery|February 9, 2026
Nationwide Analysis of Post-traumatic Breast Implant Complications: Predictors of Immediate vs Delayed Diagnosis and ManagementJade E Smith, Noelle C Garbaccio, Dorien I Schonebaum, et al.
Anticancer Research|August 5, 2010
Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumourAlicia F C Okines, Eliza A Hawkes, Sheela Rao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2018
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation OutcomesMojibade Hassan, Alina Ulezko Antonova, Jian Ming Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic miceLi-Zhen He, Naseem Prostak, Lawrence J Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemiaLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-primingMark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Pageof 2